Long noncoding RNA SNHG15 serves as an oncogene and predicts poor prognosis in epithelial ovarian cancer
Authors: Junbao Liu
Yahua Guo
Rui Qin
Chunmei Dai
Chong Qu
Journal: OncoTargets and Therapy (2018)
Discipline: CLINICAL MEDICINE
Keywords: chemoresistance; metastasis; noncoding RNA; ovarian cancer; proliferation.
Affiliations: Department of Neurosurgery, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin, People's Republic of China., Department of School Hospital, Changchun University of Chinese Medicine, Changchun 130033, Jilin, People's Republic of China., Department of Obstetrics and Gynaecology, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin, People's Republic of China, .

Abstract:  Objective: This study aims to investigate the functional role of long noncoding RNA SNHG15 in epithelial ovarian cancer (EOC). Materials and methods: The expression of SNHG15 was measured in EOC cells and tissues using qRT-PCR. The correlation of SNHG15 expression and the clinicopathological characters was statistically analyzed. The prognosis of patients with different clinical features in the high/low SNHG15 expression groups were calculated. Moreover, univariate and multivariate Cox regression analyses were performed to identify the risk factors for poor overall survival (OS) and progression-free survival (PFS). The effect of SNHG15 on the migration and invasion was evaluated using Transwell and Matrigel, respectively. The proliferation ability of EOC cells was tested using colony formation and MTT assay. The influence of SNHG15 on the cisplatin resistance was detected by measuring cell inhibition rate and cell viability. Results: SNHG15 was upegulated in EOC cells and tissues. High SNHG15 expression was correlated with EOC progression and predicted poor OS and PFS in different subgroups of EOC patients. Moreover, multivariate Cox regression analysis defined high SNHG15 expression as an independent risk factor for poor OS and PFS. Furthermore, functional assays showed that the overexpression of SNHG15 promoted migration and invasion, while the loss of SNHG15 suppressed migration and invasion. Furthermore, the proliferation of EOC cells was improved after the ectopic expression of SNHG15, which was suppressed with SNHG15 deficiency. In addition, cisplatin-resistant EOC cells were established for detecting the effect of SNHG15 on EOC chemoresistance. The results showed that cisplatin-resistant EOC cells exhibited much higher levels of SNHG15 expression than controls, and SNHG15 contributed to the chemoresistance of EOC cells. Conclusion: This study confirms that SNHG15 contributes to the migration, invasion, proliferation, and chemoresistance of EOC. SNHG15 may serve as a potential therapeutic target and prognostic biomarker of EOC patients. 

Retracted: No

PubPeer comments:
 July 2020 Expression of Concern, which reads:  The Editor and Publisher of OncoTargets and Therapy wish to issue an Expression of Concern for the published article. Questions about the scientific integrity of the articles content were brought to the Editor and Publisheru2019s attention. Despite reaching out to the authors requesting information that would confirm the articleu2019s integrity, the authors have not responded to our queries within the requested timeframe. Therefore, while we continue to work through the issues raised, we advise readers to interpret the information presented in this article with due caution. There is not much information about what the problem could be, but Figure 3E appears to have a duplication, marked here with red boxes.  ,